Barclays · REGN Holdings Trend
Regeneron Pharmaceuticals · SEC 13F
Barclays Holdings of REGN by Quarter
Quarter Shares Value
| Quarter | Shares | Value | QoQ Change |
|---|---|---|---|
| 2024Q1 | 344K | $330,732 | — |
| 2024Q2 | 350K | $367,983 | +11.3% |
| 2024Q3 | 825K | $867,790 | +135.8% |
| 2024Q4 | 385K | $274,378 | -68.4% |
| 2025Q1 | 321K | $203,815 | -25.7% |
| 2025Q2 | 966K | $507,176 | +148.8% |
| 2025Q3 | 326K | $183M | +36032.5% |
| 2025Q4 | 794K | $494M | +169.4% |
| 2026Q1 | 4.1M | $3.5B | +599.0% |
← Back to REGN holders ← Back to REGN profile
Data source: SEC EDGAR Form 13F